biotechnology company
Transine Therapeutics has raised €16M across 1 funding round from 3 investors, most recently a Seed round in Jun 2022. Based in Cambridge, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-01 | Seed | €16M |
| Dementia Discovery Fund (DDF),Epidarex Capital,Mary Canning |
| View deal → |
